Skip to main content
. 2020 Jul 23;12:65. doi: 10.1186/s13098-020-00564-w

Fig. 1.

Fig. 1

Serum concentration of asprosin in control and T2DM groups. Data shows there is a significant increase in the serum concentrations of asprosin in T2DM patients in comparison to the control group (3.50 [IQR 1.85] vs. 4.18 [IQR 4.4], P value < 0.001)